After receiving some questions about our recent @CCR_AACR paper that was mentioned a few times at last week’s @US_FDA workshop on NMIBC trials, it feels important to highlight our data that demonstrates exactly why randomized trials are critical to determine the true clinical benefit of any NMIBC treatments and why we urgently need to move beyond single arm trials for NMIBC drug approval 1/n @ElaineChangMD @chana_weinstock @BladderCancerUS @UrologyMSK @bbmdmsk @bca_md @h_alahmadie aacrjournals.org/clincancerr…

Uromigos Unsung Hero poster award! We discussed some pre-and post EV tissue data showing alterations in nectin-4 localization and expression. Possible implication for mechanisms of resistance! @OncoAlert

Congrats to our @SUO_YUO fellows @BeckySagerMDPhD (Modeling the effects of HIF2α inhibition on the ccRCC tumor microenvironment) and @aghasemzadeh1 (Understanding the Tumor Microenvironment in Non-muscle Invasive Bladder Cancer) For their @ASCO YIAs! conquer.org/cancer-research/…

@eugene_pietzak incrediblely elegant P2 on bcg Pembro in VHR T1. 92% response, 94% RC- free. 1 early death and 21% iAEs. n=37 but great job to consider risk - based strategy. #AUA26

Tomorrow at #AUA26, @eugene_pietzak will present data on combining pembrolizumab BCG in patients with BCG-naïve very high-risk T1 non-muscle invasive #BladderCancer traditionally recommended for radical cystectomy. 10:50 a.m. ET in Hall D. @AmerUrological @MSKCancerCenter Session details: bit.ly/4nvCWbU

Highly recommend this course to trainees. Performing a quality TURBT is an undepreciated skill that has major implications for our patients. The models are exceptional! @Olympus_Corp @JoshMeeks @bbmdmsk

Alliance researcher @eugene_pietzak @MSKCancerCenter leads @ALLIANCE_org A032303/GAIN-BCG, a trial evaluating a two-step treatment approach for pts w/BCG-unresponsive non–muscle-invasive #bladdercancerome. Learn more: bit.ly/Alliance-A032303 #NCI #NCTN #CancerResearch #NMIBC

The future of bladder cancer is in great hands. 👏 Stellar class of 2025 John Quale Travel Fellows! @BladderCancerUS #BCANTT25

Last week, James Eastham, MD, FACS, Urologic Surgeon at @MSKCancerCenter, joined the @NorthwesternMed Urology Chief Residents for a Lakeside Chat.

The white coats are on and Residency has started! Congratulations to our interns! #Urologist #NMBetter 🥼

Congratulations to all the @UroOnc matches today. A special congratulations to our newest class!!

Grateful for the amazing mentorship and support @JoshMeeks. True privilege to train @NM_Urology which has given me such a strong foundation to build on going forward. Excited for the next adventure! @EricLiUro @EdwardSchaeffer @UrologyMSK @UroOnc

Proud to see our work in the @JoshMeeks lab highlighted by @jitcancer. Check it out! @NM_Urology @NU_BMG_SQE

In @_backtableUro's podcast episode, Dr. @EdwardSchaeffer, department chair of #urology at @NUFeinbergMed, discusses precision medicine in prostate cancer with Dr. @AdityaBagrodia. @UroOnc @DrAdamMurphy @ashleyrossmdphd @HitenDPatel @LurieCancer open.spotify.com/episode/1By…

New #JITC short report: Spatial comparison of molecular features associated with resistance to pembrolizumab in BCG unresponsive bladder cancer bit.ly/3UkUNVL @NFryden @bonnie_choy @JoshMeeks

603.02 grams - final dry pathology report. Catheter out in < 12 hours and no transfusion despite preop admission for intractable hematuria. Bladder stone was also removed at time of enucleation. 100% endoscopic. #HoLEP @EndourologyNm @NM_Urology

RIP. Trips to DMV were slightly less terrible because I had an excuse to visit one of my favorite buildings in the city.

2️⃣ next, Dr. Eric Li, resident from @NM_Urology, presents exciting work on the performance of an AI-derived digital pathology biomarker in radical prostatectomy patients from the PLCO trial